Pliant Therapeutics (PLRX) Earnings Date, Estimates & Call Transcripts

$12.86

+0.36 (+2.88%)

(As of 12:13 PM ET)

Upcoming Earnings Date: Nov. 14Estimated
Actual EPS (Aug. 7): -$0.92 Missed By -$0.07
Consensus EPS (Aug. 7): -$0.85

PLRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PLRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad True Gold Republic

China Stockpiling Gold “Like No Tomorrow”

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.

Pliant Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	2	($0.80)	($0.71)	($0.76)
Q2 2024	2	($0.82)	($0.81)	($0.82)
Q3 2024	2	($1.00)	($0.84)	($0.92)
Q4 2024	2	($0.98)	($0.84)	($0.91)
FY 2024	8	($3.60)	($3.20)	($3.40)
Q1 2025	1	($0.97)	($0.97)	($0.97)
Q2 2025	1	($0.97)	($0.97)	($0.97)
Q3 2025	1	($0.95)	($0.95)	($0.95)
Q4 2025	1	($0.94)	($0.94)	($0.94)
FY 2025	4	($3.83)	($3.83)	($3.83)

PLRX Earnings Date and Information

Pliant Therapeutics last released its quarterly earnings results on August 7th, 2024. The reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.85) by $0.07. Pliant Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Pliant Therapeutics are expected to decrease in the coming year, from ($3.71) to ($4.03) per share. Pliant Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.

Pliant Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/14/2024 (Estimated)	-	-	-	-	-	-	-
8/7/2024	-	($0.85)	($0.92)	($0.07)	($0.92)	-	-
5/6/2024	Q1 2024	($0.76)	($0.78)	($0.02)	($0.78)	-	-
11/9/2023	Q3 2023	($0.78)	($0.70)	+$0.08	($0.70)	-	-
8/9/2023	Q2 2023	($0.73)	($0.70)	+$0.03	($0.70)	$1.10 million	$0.25 million
5/9/2023	Q1 2023	($0.66)	($0.67)	($0.01)	($0.67)	$1.96 million	$1.33 million
3/9/2023	Q4 2022	($0.70)	($0.72)	($0.02)	($0.72)	$1.55 million	$1.97 million
Get the Latest News and Ratings for PLRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
11/8/2022	Q3 2022	($0.74)	($0.65)	+$0.09	($0.65)	$2.26 million	$1.48 million
8/8/2022	Q2 2022	($0.82)	($0.82)	-	($0.82)	$1.35 million	$4.99 million
5/9/2022	Q1 2022	($0.77)	($0.78)	($0.01)	($0.78)	$1.43 million	$1.25 million
2/28/2022	Q4 2021	($0.76)	($0.68)	+$0.08	($0.68)	$3.70 million	$2.00 million
11/9/2021	Q3 2021	($0.69)	($0.75)	($0.06)	($0.75)	$2.50 million	$1.61 million
8/9/2021	Q2 2021	($0.67)	($0.64)	+$0.03	($0.64)	-	$1.79 million
5/10/2021	Q1 2021	($0.60)	($0.64)	($0.04)	($0.64)	-	$2.17 million
3/15/2021	Q4 2020	($0.71)	($0.54)	+$0.17	($0.54)	$2.60 million	$4.47 million
11/10/2020	Q3 2020	($0.85)	($0.47)	+$0.38	($0.47)	-	$4.81 million
8/11/2020	Q2	($0.7730)	($1.39)	($0.6170)	($1.39)	-	$3.60 million

Pliant Therapeutics Earnings - Frequently Asked Questions

When is Pliant Therapeutics's earnings date?: Pliant Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on PLRX's earnings history.
Did Pliant Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Pliant Therapeutics (NASDAQ:PLRX) missed the analysts' consensus estimate of ($0.85) by $0.07 with a reported earnings per share (EPS) of ($0.92). Learn more on analysts' earnings estimate vs. PLRX's actual earnings.
How can I listen to Pliant Therapeutics's earnings conference call?: The conference call for Pliant Therapeutics's latest earnings report can be listened to online. Listen to Conference Call
How can I read Pliant Therapeutics's conference call transcript?: The conference call transcript for Pliant Therapeutics's latest earnings report can be read online. Read Transcript
How much revenue does Pliant Therapeutics generate each year?: Pliant Therapeutics (NASDAQ:PLRX) has a recorded annual revenue of $1.58 million.
How much profit does Pliant Therapeutics generate each year?: Pliant Therapeutics (NASDAQ:PLRX) has a recorded net income of -$161.34 million. PLRX has generated $0.00 earnings per share over the last four quarters.
What is Pliant Therapeutics's EPS forecast for next year?: Pliant Therapeutics's earnings are expected to decrease from ($3.71) per share to ($4.03) per share in the next year.